Sign in or create an account to add this stock to your watchlist.
About Tekla Healthcare (NYSE:HQH)
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Industry, Sector and Symbol
Industry Investment offices, not elsewhere classified
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Tekla Healthcare (NYSE:HQH) Frequently Asked Questions
What is Tekla Healthcare's stock symbol?
Tekla Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH."
How often does Tekla Healthcare pay dividends? What is the dividend yield for Tekla Healthcare?
Tekla Healthcare declared a quarterly dividend on Wednesday, May 23rd. Shareholders of record on Friday, June 1st will be given a dividend of $0.47 per share on Friday, June 29th. This represents a $1.88 dividend on an annualized basis and a yield of 8.74%. The ex-dividend date of this dividend is Thursday, May 31st. View Tekla Healthcare's Dividend History.
Who are some of Tekla Healthcare's key competitors?
Some companies that are related to Tekla Healthcare include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity (ADX), Tri Continental (TY), Gabelli Equity Trust (GAB), PIMCO Cor & Inc Opp Fds (PTY), Tortoise Energy Infrastructure (TYG), Royce Value Trust (RVT), Apollo Investment (AINV), Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund Inc common stock (BIF), Hercules Technology Growth Capital (HTGC), PIMCO High Income Fund (PHK), Alliance World Dollar Government Fund II (AWF) and Solar Capital (SLRC).
Who are Tekla Healthcare's key executives?
Tekla Healthcare's management team includes the folowing people:
- Dr. Daniel R. Omstead M.S, Ph.D., CEO, Pres & Trustee
- Ms. Kimberley L. Carroll, CFO, CFO - HQL Fund, VP & Treasurer of Hambrecht & Quist Capital Mgmt LLC
- Ms. Laura F. Woodward CPA, Chief Compliance Officer, Treasurer and Sec.
- Dr. Jason C. Akus M.D., MBA, VP of Research and Portfolio Mang.
- Mr. Christopher F. Brinzey MBA, Sr. VP of Research and Portfolio Mang.
Has Tekla Healthcare been receiving favorable news coverage?
News articles about HQH stock have trended somewhat positive on Sunday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Tekla Healthcare earned a news sentiment score of 0.19 on Accern's scale. They also gave media coverage about the financial services provider an impact score of 47.06 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
Who are Tekla Healthcare's major shareholders?
Tekla Healthcare's stock is owned by many different of institutional and retail investors. Top institutional investors include City of London Investment Management Co. Ltd. (1.18%), Royal Bank of Canada (1.04%), UBS Group AG (0.85%), Wells Fargo & Company MN (0.60%), Punch & Associates Investment Management Inc. (0.54%) and Thomas J. Herzfeld Advisors Inc. (0.19%). View Institutional Ownership Trends for Tekla Healthcare.
Which major investors are selling Tekla Healthcare stock?
HQH stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, HL Financial Services LLC, NINE MASTS CAPITAL Ltd, Royal Bank of Canada and Punch & Associates Investment Management Inc.. View Insider Buying and Selling for Tekla Healthcare.
Which major investors are buying Tekla Healthcare stock?
HQH stock was purchased by a variety of institutional investors in the last quarter, including City of London Investment Management Co. Ltd., Mutual Advisors LLC, Thomas J. Herzfeld Advisors Inc., Shaker Financial Services LLC, Stifel Financial Corp, LPL Financial LLC, First Republic Investment Management Inc. and UBS Group AG. View Insider Buying and Selling for Tekla Healthcare.
How do I buy shares of Tekla Healthcare?
Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tekla Healthcare's stock price today?
One share of HQH stock can currently be purchased for approximately $21.51.
How big of a company is Tekla Healthcare?
Tekla Healthcare has a market capitalization of $874.36 million.
How can I contact Tekla Healthcare?
Tekla Healthcare's mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at 617-772-8500 or via email at [email protected]
MarketBeat Community Rating for Tekla Healthcare (HQH)MarketBeat's community ratings are surveys of what our community members think about Tekla Healthcare and other stocks. Vote "Outperform" if you believe HQH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQH will underperform the S&P 500 over the long term. You may vote once every thirty days.
Tekla Healthcare (NYSE:HQH) Analyst Ratings History
(Data available from 5/27/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Tekla Healthcare (NYSE:HQH) Dividend Information
Tekla Healthcare pays an annual dividend of $0.48 per share, with a dividend yield of 2.23%. HQH's next quarterly dividend payment will be made on Friday, June 29.
|Dividend Growth:||-3.70% (3 Year Average)|
Tekla Healthcare (NYSE:HQH) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Tekla Healthcare (NYSE HQH) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.00%
Institutional Ownership Percentage: 19.86%
Tekla Healthcare (NYSE HQH) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|1/25/2018||Thomas M Kent||Director||Buy||1,100||$24.19||$26,609.00||1,100|| |
|1/6/2016||Timothy L Gasperoni||SVP||Buy||862||$28.98||$24,980.76||862|| |
Tekla Healthcare (NYSE HQH) News Headlines
Tekla Healthcare (NYSE:HQH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Tekla Healthcare (NYSE:HQH) Income Statement, Balance Sheet and Cash Flow Statement
Tekla Healthcare (NYSE HQH) Stock Chart for Sunday, May, 27, 2018